Programmed cell death-1 (PD1) on T cells, and programmed death-ligand 1 (PDL1) on tumors comprise an immunosuppressive axis within the TME and have been shown to play a pivotal role in GBM progression (14, 15). This evidence concerns the gene PDCD1 and glioblastoma.